MedPath

Typhlitis study.

Recruiting
Conditions
Acute myeloid leukemiaAcute myeloide leukemie
Registration Number
NL-OMON21843
Lead Sponsor
Prof.dr. E. VellengaDept. of HematologyUniversity Medical Center GroningenP.O. Box 30.0019700 RB GroningenThe NetherlandsPhone: +31 50 361 61 61E-mail: e.vellenga2int.umcg.nl
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
45
Inclusion Criteria

1. Age 18-70 years;

2. Diagnosed with AML and treated with intensive chemotherapy.

Exclusion Criteria

Ineligible to perform the tests.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Defining the severity of epithelial dysfunction measured with mucositis score, the stool volume, the calprotectin level in the stool, the urinary Cr EDTA excretion and serum IL-8 and CRP levels;<br /><br>2. Typhlitis based on clinical symptomatology and CT-scanning abdomen.<br>
Secondary Outcome Measures
NameTimeMethod
Before and after treatment with chemo different parameters will be examined.
© Copyright 2025. All Rights Reserved by MedPath